Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Odette Gore

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Diabetes & Vascular Disease Research|July 17, 2014
Is cardiorespiratory fitness a determinant of cardiomyopathy in the setting of type 2 diabetes?Martin Sénéchal, Colby R Ayers, Lidia S Szczepaniak, et al.
JAMA Cardiology|May 23, 2019
Identifying Familial Hypercholesterolemia Using a Blood Donor Screening Program With More Than 1 Million Volunteer DonorsCandace L Jackson, James Z Keeton, Stephen J Eason, et al.
Diabetes & Vascular Disease Research|November 10, 2011
The effects of rosiglitazone on myocardial triglyceride content in patients with type 2 diabetes: a randomised, placebo-controlled trialJonathan McGavock, Lidia S Szczepaniak, Colby R Ayers, et al.
Journal of the American Heart Association|September 14, 2019
Racial Differences in Cardiovascular Biomarkers in the General PopulationEddie Hackler, Jeanney Lew, M Odette Gore, et al.
American Heart Journal|March 30, 2013
Discordant effects of rosiglitazone on novel inflammatory biomarkersElan Gada, Andrew W Owens, M Odette Gore, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 7, 2013
Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart studyM Odette Gore, Nicole Lüneburg, Edzard Schwedhelm, et al.
American Heart Journal|September 1, 2014
Type of β-blocker use among patients with versus without diabetes after myocardial infarctionSuzanne V Arnold, John A Spertus, Kasia J Lipska, et al.
Circulation. Cardiovascular Quality and Outcomes|November 8, 2012
Diabetes mellitus and trends in hospital survival after myocardial infarction, 1994 to 2006: data from the national registry of myocardial infarctionM Odette Gore, Mahesh J Patel, Mikhail Kosiborod, et al.
Circulation|October 1, 2013
Inaccuracy of estimated resting oxygen uptake in the clinical settingNikhil Narang, Jennifer T Thibodeau, Benjamin D Levine, et al.
Diabetes & Vascular Disease Research|December 25, 2015
Effect of treatment with rosiglitazone on high-sensitivity cardiac troponin levels among patients with type 2 diabetes mellitusUsman I Salahuddin, Ambarish Pandey, Colby R Ayers, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Diabetes & Vascular Disease Research|July 17, 2014
Is cardiorespiratory fitness a determinant of cardiomyopathy in the setting of type 2 diabetes?Martin Sénéchal, Colby R Ayers, Lidia S Szczepaniak, et al.
JAMA Cardiology|May 23, 2019
Identifying Familial Hypercholesterolemia Using a Blood Donor Screening Program With More Than 1 Million Volunteer DonorsCandace L Jackson, James Z Keeton, Stephen J Eason, et al.
Diabetes & Vascular Disease Research|November 10, 2011
The effects of rosiglitazone on myocardial triglyceride content in patients with type 2 diabetes: a randomised, placebo-controlled trialJonathan McGavock, Lidia S Szczepaniak, Colby R Ayers, et al.
Journal of the American Heart Association|September 14, 2019
Racial Differences in Cardiovascular Biomarkers in the General PopulationEddie Hackler, Jeanney Lew, M Odette Gore, et al.
American Heart Journal|March 30, 2013
Discordant effects of rosiglitazone on novel inflammatory biomarkersElan Gada, Andrew W Owens, M Odette Gore, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 7, 2013
Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart studyM Odette Gore, Nicole Lüneburg, Edzard Schwedhelm, et al.
American Heart Journal|September 1, 2014
Type of β-blocker use among patients with versus without diabetes after myocardial infarctionSuzanne V Arnold, John A Spertus, Kasia J Lipska, et al.
Circulation. Cardiovascular Quality and Outcomes|November 8, 2012
Diabetes mellitus and trends in hospital survival after myocardial infarction, 1994 to 2006: data from the national registry of myocardial infarctionM Odette Gore, Mahesh J Patel, Mikhail Kosiborod, et al.
Circulation|October 1, 2013
Inaccuracy of estimated resting oxygen uptake in the clinical settingNikhil Narang, Jennifer T Thibodeau, Benjamin D Levine, et al.
Diabetes & Vascular Disease Research|December 25, 2015
Effect of treatment with rosiglitazone on high-sensitivity cardiac troponin levels among patients with type 2 diabetes mellitusUsman I Salahuddin, Ambarish Pandey, Colby R Ayers, et al.
Pageof 3